Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFOTAXIME\CEFOTAXIME: 84 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
84
Total FAERS Reports
23 (27.4%)
Deaths Reported
34
Hospitalizations
84
As Primary/Secondary Suspect
11
Life-Threatening
2
Disabilities

Active Ingredient: CEFOTAXIME\CEFOTAXIME SODIUM ·

First Report: 20070716 · Latest Report: 20150506

What Are the Most Common CEFOTAXIME\CEFOTAXIME Side Effects?

#1 Most Reported
Pyrexia
12 reports (14.3%)
#2 Most Reported
Dermatitis exfoliative
10 reports (11.9%)
#3 Most Reported
Rash
9 reports (10.7%)

All CEFOTAXIME\CEFOTAXIME Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Pyrexia 12 14.3% 2 11
Dermatitis exfoliative 10 11.9% 1 2
Drug ineffective 9 10.7% 8 3
Rash 9 10.7% 0 7
Drug reaction with eosinophilia and systemic symptoms 7 8.3% 0 7
Impaired healing 7 8.3% 0 1
Pruritus 7 8.3% 0 0
Death 6 7.1% 6 0
Dry skin 6 7.1% 0 0
Enterococcal infection 6 7.1% 5 1
Hepatocellular injury 6 7.1% 0 5
Leukopenia 6 7.1% 0 3
Neutropenia 6 7.1% 0 5
Sepsis 6 7.1% 4 3
Skin exfoliation 6 7.1% 0 1
Anaemia 5 6.0% 1 4
Hypotension 5 6.0% 0 1
Pancytopenia 5 6.0% 1 4
Pathogen resistance 5 6.0% 2 1
Thrombocytopenia 5 6.0% 1 4

Who Reports CEFOTAXIME\CEFOTAXIME Side Effects? Age & Gender Data

Gender: 51.9% female, 48.1% male. Average age: 43.0 years. Most reports from: FR. View detailed demographics →

Is CEFOTAXIME\CEFOTAXIME Getting Safer? Reports by Year

YearReportsDeathsHosp.
2007 2 0 1
2008 1 0 1
2009 1 0 1
2012 1 1 1
2013 1 0 0
2014 17 3 10
2015 18 3 6

View full timeline →

What Is CEFOTAXIME\CEFOTAXIME Used For?

IndicationReports
Product used for unknown indication 24
Pneumonia 8
Infection 5

Official FDA Label for CEFOTAXIME\CEFOTAXIME

Official prescribing information from the FDA-approved drug label.